CDH2 and breast cancer: Using GraphPad Prism to analyze the expression levels of LINC00536, CDH2, and mir‐204, the results indicated that the expression levels of LINC00536 and CDH2 were increased in breast cancer (Figures 7A,B and 8A,B), while mir‐204 expression was decreased (Figures 7C and 8C).